Esomeprazole 20 MG Delayed Release Oral Capsule [Nexium] — RxCUI 606728
RxNorm drug concept · Semantic branded drug
RxCUI 606728
Semantic branded drug · SBD
● Current RxNorm concept 10 FDA products
19 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI606728
Official nameEsomeprazole 20 MG Delayed Release Oral Capsule [Nexium]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNexium 20 MG Delayed Release Oral Capsule; Nexium 20 MG (as esomeprazole magnesium 22.3 MG) Delayed Release Oral Capsule; Nexium 24 HR 20 MG Delayed release Oral Capsule
FDA products mapped10
Package NDCs mapped19
Reported Medicaid activity (SDUD)105,428 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Esomeprazole Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used for erosive esophagitis from GERD when taking esomeprazole by mouth isn't possible or appropriate. It is also used in adults to lower the risk of bleeding again from sto...
- Why am I getting esomeprazole through an IV?
- For GERD, it is given for up to 10 days, and you switch to an oral form as soon as you can. For bleeding ulcers, the IV course lasts about 72 hours, and then you take an oral acid...
- The most common are headache, gas, nausea, stomach pain, diarrhea, dry mouth, dizziness and irritation at the IV site. Let your nurse know if the IV site is painful, red or swollen...
🕸️ Concept Web — How Esomeprazole 20 MG Delayed Release Oral Capsule... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Esomeprazole 20 MG Delayed Release Oral Capsule [Nexium]
RxCUI 606728 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Esomeprazole
283742IN
-
Esomeprazole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nexium
284799BN
-
Nexium
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Esomeprazole Delayed Release Oral Capsule
606725SCDF -
Esomeprazole Oral Product
1165149SCDG -
Esomeprazole Pill
1165150SCDG -
Esomeprazole Delayed Release Oral Capsule [Nexium]
606727SBDF -
Nexium Oral Product
1182869SBDG -
Nexium Pill
1182870SBDG -
Delayed Release Oral Capsule
316995DF -
Oral Product
1151131DFG - +1 more in this family
-
Esomeprazole Delayed Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Esomeprazole 20 MG Delayed Release Oral Capsule
606726SCD -
Esomeprazole 20 MG
343355SCDC -
Esomeprazole 20 MG [Nexium]
574982SBDC
-
Esomeprazole 20 MG Delayed Release Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Esomeprazole 20 MG Delayed Release Oral Capsule
SCD · 606726 -
Esomeprazole 20 MG
SCDC · 343355 -
Esomeprazole Delayed Release Oral Capsule
SCDF · 606725 -
Esomeprazole Oral Product
SCDG · 1165149 -
Esomeprazole Pill
SCDG · 1165150
Brand-Name Concepts
-
Esomeprazole 20 MG [Nexium]
SBDC · 574982 -
Esomeprazole Delayed Release Oral Capsule [Nexium]
SBDF · 606727 -
Nexium Oral Product
SBDG · 1182869 -
Nexium Pill
SBDG · 1182870 -
Nexium
BN · 284799
📦 FDA Products & Package NDCs
10 products · 19 package NDCs
19 package NDCs map to RxCUI 606728 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00186-4010-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4010-01) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2008-07-07 |
| 00186-4020-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4020-01) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2007-03-19 |
| 00186-4025-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4025-01) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2012-09-05 |
| 00186-4040-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4040-01) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2007-03-19 |
| 00186-4050-01 | 30 GRANULE, DELAYED RELEASE in 1 CARTON (0186-4050-01) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2012-09-05 |
| 00186-5020-31 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0186-5020-31) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2001-03-19 |
| 00186-5020-54 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0186-5020-54) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2001-03-19 |
| 00186-5040-31 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0186-5040-31) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2001-03-19 |
| 00186-5040-54 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0186-5040-54) | NEXIUM | AstraZeneca Pharmaceuticals LP | 2001-03-19 |
| 00573-2450-02 | 1 BLISTER PACK in 1 CARTON (0573-2450-02) / 2 CAPSULE, DELA... | Nexium 24HR | Haleon US Holdings LLC | 2014-10-31 |
| 00573-2450-14 | 1 BOTTLE in 1 CARTON (0573-2450-14) / 14 CAPSULE, DELAYED R... | Nexium 24HR | Haleon US Holdings LLC | 2014-05-27 |
| 00573-2450-28 | 2 BOTTLE in 1 CARTON (0573-2450-28) / 14 CAPSULE, DELAYED R... | Nexium 24HR | Haleon US Holdings LLC | 2014-05-27 |
| 00573-2450-42 | 3 BOTTLE in 1 CARTON (0573-2450-42) / 14 CAPSULE, DELAYED R... | Nexium 24HR | Haleon US Holdings LLC | 2014-05-27 |
| 00573-2450-43 | 3 BOTTLE in 1 BLISTER PACK (0573-2450-43) / 14 CAPSULE, DEL... | Nexium 24HR | Haleon US Holdings LLC | 2014-05-27 |
| 00573-2450-44 | 3 BOTTLE in 1 CARTON (0573-2450-44) / 14 CAPSULE, DELAYED R... | Nexium 24HR | Haleon US Holdings LLC | 2014-05-27 |
| 00573-2452-02 | 1 BLISTER PACK in 1 CARTON (0573-2452-02) / 2 CAPSULE, DELA... | Nexium 24HR ClearMinis | Haleon US Holdings LLC | 2017-03-01 |
| 00573-2452-14 | 1 BOTTLE in 1 CARTON (0573-2452-14) / 14 CAPSULE, DELAYED R... | Nexium 24HR ClearMinis | Haleon US Holdings LLC | 2017-03-01 |
| 00573-2452-42 | 3 BOTTLE in 1 CARTON (0573-2452-42) / 14 CAPSULE, DELAYED R... | Nexium 24HR ClearMinis | Haleon US Holdings LLC | 2017-03-01 |
| 50090-1492-00 | 3 BOTTLE in 1 CARTON (50090-1492-0) / 14 CAPSULE, DELAYED R... | Nexium 24HR | A-S Medication Solutions | 2014-12-04 |
Observed labelers:
AstraZeneca Pharmaceuticals LP (9) ·
Haleon US Holdings LLC (9) ·
A-S Medication Solutions (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.